FDA drug class
Antidiarrheals list
Every FDA-approved prescription drug the FDA NDC directory tags with the Antidiarrheal [EPC] class, with brand names and DEA schedules.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
The FDA NDC directory lists 1 single-ingredient drug in this class: crofelemer. Another 2 combination products include one of them.
Run it in Rivvi
Map Mytesi and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Antidiarrheals (3)
| Drug | Brand names | Type | NDC listings | DEA schedule |
|---|---|---|---|---|
| Crofelemer | Mytesi | Single ingredient | 1 | Not controlled |
| Difenoxin and atropine | Motofen | Combination | 2 | Schedule IV |
| Diphenoxylate and atropine | Lomotil | Combination | 28 | Schedule V |
FDA established pharmacologic class: Antidiarrheal [EPC].
Questions
What drugs are Antidiarrheals?
The FDA NDC directory lists 1 single-ingredient drug in this class: crofelemer. Another 2 combination products include one of them.
Where does this list come from?
From the established pharmacologic class (EPC) field FDA publishes for each listing in the NDC directory. A drug is listed when most of its prescription listings carry the class.